Clinical Trial Update: Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER) [Phase 3]

View source ↗

Summary

The FibER Phase 3 trial evaluating fibrinogen replacement to prevent intracranial hemorrhage in ischemic stroke patients after thrombolysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Hemorrhage
• Stroke

Drugs mentioned

• Fibrinogen concentrate (Fibrinogen concentrate)

Snippet

Sponsor: Azienda Usl di Bologna | Conditions: Intracranial Hemorrhages, Ischemic Stroke | Phase 3 | Status: COMPLETED